We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Medicine

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is Erlotinib?

Mary McMahon
By
Updated: May 17, 2024

Erlotinib is an antineoplastic agent, a drug designed to be used in the treatment of cancer. This medication is available in the form of an oral tablet taken by the patient at set intervals. Like other chemotherapy drugs, it is prescribed by an oncologist in consultation with the patient and other care providers, and it is available by prescription only to limit the risks of unauthorized use of the medication. People should store their erlotinib in a cool, dry place out of reach of children and pets.

This drug is a type of targeted cancer therapy, developed to single out specific types of cells while avoiding damage to healthy cells. It blocks an enzyme known as epidermal growth factor, inhibiting the growth of cancerous tumors. It is most commonly used in the treatment of metastatic non-small cell lung cancer, although it can also be prescribed for pancreatic cancer and other types of cancers. Erlotinib may be used as a standalone medication or as part of combination chemotherapy.

Before prescribing erlotinib, a doctor will review a patient's medical history. Certain conditions like a prior history of heart attacks can be contraindicators for this drug, and if the patient is taking other medications, including over the counter drugs and herbal supplements, it may be necessary to stop these medications for the duration of chemotherapy to avoid adverse drug interactions. Patients need to make sure their medical history is accurate, as failing to disclose a medication or past medical problem could be dangerous.

People preparing to take erlotinib also need to be aware of the impact of the drug on fertility. After taking the drug, it may not be possible to have children, and pregnant women should not take this drug, as it can cause severe birth defects. In cases where the patient absolutely must start chemotherapy immediately, termination of the pregnancy may be recommended. People concerned about fertility can discuss the possibility of banking eggs, sperm, or embryos for future use.

Common erlotinib side effects include eye irritation, nausea, and fatigue. Some people develop allergic reactions to the drug, and it is important to report symptoms like hives and difficulty breathing. In addition, the drug exposes people to the risk of lung infections. Patients who have trouble breathing or develop coughs while on this medication should discuss the situation with their doctors to see if they need to be screened for infections in the lungs.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a WiseGeek researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
Share
https://www.wisegeek.net/what-is-erlotinib.htm
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.